Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Federico Cappuzzo
Crizotinib in MET Deregulated or ROS1 Rearranged Pretreated Non-Small-Cell Lung Cancer (METROS): A Phase II, Prospective, Multicentre, Two-Arms Trial
Clinical Cancer Research
Cancer Research
Oncology
HER2 Deregulation in Lung Cancer: Right Time to Adopt an Orphan?
Clinical Cancer Research
Cancer Research
Oncology
Real-World Efficacy and Safety of Nivolumab in Previously-Treated Metastatic Renal Cell Carcinoma, and Association Between Immune-Related Adverse Events and Survival: The Italian Expanded Access Program
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
P95HER2 Truncated Form in Resected Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Italian Cohort of Nivolumab Expanded Access Program in Squamous Non‐Small Cell Lung Cancer: Results From a Real‐World Population
Oncologist
Cancer Research
Medicine
Oncology
Efficacy of Nivolumab in Pre-Treated Non-Small-Cell Lung Cancer Patients Harbouring KRAS Mutations
British Journal of Cancer
Cancer Research
Oncology
Overcoming Resistance to First/Second Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and ALK Inhibitors in Oncogene-Addicted Advanced Non-Small Cell Lung Cancer
Therapeutic Advances in Medical Oncology
Oncology
Meeting Report: 2nd Meeting of the European Thoracic Oncology Platform (ETOP)
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Outcomes in Patients With Aggressive or Refractory Disease From REVEL, a Randomized Phase III Study of Docetaxel With Ramucirumab or Placebo for Second-Line Treatment of Stage IV Non-Small-Cell Lung Cancer
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Lung Cancer Update 2017: From the Test Tube to the Bed
Annals of Translational Medicine
Medicine
1
2
›
